Paratek Pharmaceuticals

Paratek Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company's medical research is based on tetracycline chemistry and biology, creating two antibacterial drugs: omadacycline and sarecycline. Omadacycline is an antibacterial drug used for the treatment of skin infections and community-acquired bacterial pneumonia. Sarecycline is designed to treat acne and rosacea. Paratek Pharmaceuticals is also involved in research on the treatment of multiple sclerosis, spinal muscular atrophy, and systemic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.